As machine learning (ML) increasingly affects people and society, awareness of its potential unwanted consequences has also grown. To anticipate, prevent, and mitigate undesirable downstream consequences, it is critical that we understand when and how harm might be introduced throughout the ML life cycle. In this paper, we provide a framework that identifies seven distinct potential sources of downstream harm in machine learning, spanning data collection, development, and deployment. In doing so, we aim to facilitate more productive and precise communication around these issues, as well as more direct, application-grounded ways to mitigate them.

Artificial intelligence (AI) models for decision support have been developed for clinical settings such as radiology, but little work evaluates the potential impact of such systems. In this study, physicians received chest X-rays and diagnostic advice, some of which was inaccurate, and were asked to evaluate advice quality and make diagnoses. All advice was generated by human experts, but some was labeled as coming from an AI system. As a group, radiologists rated advice as lower quality when it appeared to come from an AI system; physicians with less task-expertise did not. Diagnostic accuracy was significantly worse when participants received inaccurate advice, regardless of the purported source. This work raises important considerations for how advice, AI and non-AI, should be deployed in clinical environments.

No abstract

To ensure accountability and mitigate harm, it is critical that diverse stakeholders can interrogate black-box automated systems and find information that is understandable, relevant, and useful to them. In this paper, we eschew prior expertise-and role-based categorizations of interpretability stakeholders in favor of a more granular framework that decouples stakeholders' knowledge from their interpretability needs. We characterize stakeholders by their formal, instrumental, and personal knowledge and how it manifests in the contexts of machine learning, the data domain, and the general milieu. We additionally distill a hierarchical typology of stakeholder needs that distinguishes higher-level domain goals from lower-level interpretability tasks. In assessing the descriptive, evaluative, and generative powers of our framework, we find our more nuanced treatment of stakeholders reveals gaps and opportunities in the interpretability literature, adds precision to the design and comparison of user studies, and facilitates a more reflexive approach to conducting this research.

Tubular particles presenting heterogeneous regions of chemistry on the tube-ends versus the side are fabricated and are shown to control the particle orientation on the surface of live lymphocytes. Controlling the orientation of anisotropic microparticles on cell surfaces is of interest for biomedical applications and drug delivery in particular, since it can be used to promote or resist particle internalization.